Nicotinamide reduces tumour interstitial fluid pressure in a dose- and time-dependent manner

British Journal of Radiology

Volumn 70, Issue FEB., 1997, Pages 160-167

  Peters, C E ^a,b   Chaplin, D J ^a   Hirst, D G ^a,c  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF ULSTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINAMIDE;

ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CARCINOMA; CONTROLLED STUDY; FEMALE; MICROPIPETTE; MOUSE; NONHUMAN; RADIATION RESPONSE; RADIOSENSITIZATION; TISSUE PRESSURE;

EID: 0031047791     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.70.830.9135442     Document Type: Article

References (34)

1. Chaplin DJ, Horsman MR, Aoki DS. Nicotinamide, Fluosol DA and carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo. Br J Cancer 1991;63:109-13.
2. Horsman MR, Brown DM, Lemmon MJ, et al. Preferential tumour radiosensitization by analogues of nicotinamide and benzamide. Int J Radiat Oncol Biol Phys 1986;12:1307-10.
3. Horsman MR, Chaplin DJ, Brown JM. - Radiosensitization by nicotinamide in vivo: a greater enhancement of tumour damage compared to that of normal tissue. Radiat Res 1987;109:479-89.
4. Horsman MR, Wood PJ, Chaplin DJ, et al. The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivo. Radiother Oncol 1990;18:49-57.
5. 3H mouse mammary adenocarcinoma. Radiother Oncol 1984;1:349-53.
6. 3H mammary carcinoma. Eur J Cancer Clin Oncol 1989;25:1733-7.
7. Kjellén E, Joiner MC, Collier JM, et al. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments. Radiother Oncol 1991;22:81-91.
8. Brown JM, Lemmon MJ, Horsman MR, Lee WW. Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamide. Int J Radiat Biol 1991;59:739-48.
9. Horsman MR, Chaplin DJ, Brown JM. Tumour radiosensitization by nicotinamide: a result of improved perfusion and oxygenation. Radiat Res 1989;118:139-50.
10. Hirst DG, Joiner B, Hirst VK. Blood flow modification by nicotinamide and metoclopramide in mouse tumours growing in different sites. Br J Cancer 1993;67:1-6.
11. Horsman MR, Brown JM, Hirst VK, et al. Mechanism of action of selective tumour radiosensitizer nicotinamide. Int J Radiat Oncol Biol Phys 1988;15:685-90.
12. 3H mouse mammary carcinoma and CDF1 mice. Int J Radiat Oncol Biol Phys 1992;22:451-4.
13. Stone HB, Minchinton AI, Lemmon M, et al. Pharmacological modification of tumour blood flow: lack of correlation between alteration of mean arterial blood pressure and changes in tumour perfusion. Int J Radiat Oncol Biol Phys 1991;22:79-86.
14. Chaplin DJ, Horsman MR, Trotter MJ. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumour. J Natl Cancer Inst 1990;82:672-6.
15. Horsman MR, Overgaard J, Christensen KL, et al. Mechanism for the reduction of tumour hypoxia by nicotinamide and the clinical relevance for radiotherapy. Biomed Biochim Acta 1989;48:S251-S254.
16. Chaplin DJ, Horsman MR, Siemann DW. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time. Br J Cancer 1993;68:269-73.
17. Horsman MR, Siemann DW, Nordsmark M, et al. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment. Adv Exp Med Biol 1994;361:635-42.
18. 2 measurements. In: 41st Annual Meeting of the Radiation Research Society. Dallas: Radiation Research Society, 1993:113.
19. Kelleher DK, Vaupel PW. Nicotinamide exerts different acute effects on microcirculatory function and tissue oxygenation in rat tumours. Int J Radiat Oncol Biol Phys 1993;26:95-102.
20. Lee I, Song CW. The oxygenation of murine tumour isografts and human tumour xenografts by nicotinamide. Radiat Res 1992;130:65-71.
21. Horsman MR, Høyer M, Honess DJ, et al. Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy. Radiother Oncol 1993;27:131-9.
22. Rojas A, Johns H, Russell P. Tumour radiosensitization with carbogen and nicotinamide at clinically relevant doses per fraction. Radiother Oncol 1992;24 (Suppl.):S114.
23. Lee I, Boucher Y, Jain RK. Nicotinamide can lower tumour interstitial fluid pressure: mechanistic and therapeutic implications. Cancer Res 1992;52:3237-40.
24. Wiederhielm CA, Westin BV. Microvascular, lymphatic, and tissue pressures in the unanaesthetized mammal. Am J Physiol 1973;225:992-6.
25. Trotter MJ, Chaplin DJ, Durand RE, Olive PL. The use of fluorescent probes to identify regions of transient perfusion in murine tumours. Int J Radiat Oncol Biol Phys 1989;16:931-4.
26. Horsman MR, Evans JW, Brown JM. Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms. Br J Cancer 1984;50:305-16.
27. Sims PJ, Waggoner AS, Wang C-H, Hoffman JF. Studies on the mechanism by which cyanine dyes measure membrane potential in red blood cells and phosphatidylcholine vesicles. Biochem 1974;13:3315-3330.
28. Andersson K-E. Clinical pharmacology of potassium channel openers. Pharmacol Toxicol 1992;70:244-54.
29. Morgan SA, Watson JV, Twentyman PR, Smith PJ. Flow cytometric analysis of Hoechst 33342 uptake as an indicator of multi-drug resistance in human lung cancer. Br J Cancer 1989;60:282-7.
30. Wennerberg J, Kjellén E, Lybak S, et al. Biochemical modulation of chemotherapy and radiotherapy in head and neck cancer. Anticancer Res 1993; 13:2501-6.
31. Horsman MR, Christensen KL, Overgaard J. Importance of nicotinamide dose on blood pressure changes in mice and humans. Int J Radiat Oncol Biol Phys 1994;29:455-458.
32. Hirst DG, Kennovin GD, Flitney FW. The radiosensitizer nicotinamide inhibits arterial vasoconstriction. Br J Radiol 1994;67:795-9.
33. Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumours: implications for vascular collapse. Cancer Res 1992;52:5110-14.
34. Siemann DW, Chaplin DJ, Horsman MR. The effect of nicotinamide treatment and carbogen breathing on the radiation response of the KHT sarcoma. In 41st Annual Meeting of the Radiation Research Society. Dallas: Radiation Research Society, 1993:113.